Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
Vishnu Priya Pulipati, Founder and Host of LipidCurious Podcast, Member of Institutional Review Ethics Board at Saint Francis Health System, shared on LinkedIn:
”Let’s talk about statins. I know… boring, right?
Most of us already know a lot about them.
But thinking of statins only as cholesterol drugs misses the bigger picture.
In many ways, statins are best understood as Anti-atherosclerotic therapies that modify plaque biology, vascular inflammation, and cardiovascular risk far beyond simple LDL reduction.
In this episode, we cover:
- Pleiotropic effects of statins beyond LDL-C lowering
- Choosing the right statin in special populations
- Why statins remain foundational therapy even in the era of newer lipid-lowering drugs
Bonus: Visual guide to help you navigate the episode.
Free CME/CE available for listening.
Listen at www.lipidcurious.com, Apple Podcasts, Spotify, or YouTube Podcasts.
Want a companion resource? Download the free LipidCurious Starter Kit.
Questions or feedback? [email protected]
Disclaimer: Educational content only. Not medical advice.
Clinicians should use independent clinical judgment and applicable guidelines.”
Stay updated with Hemostasis Today.
-
Mar 14, 2026, 19:19Yunpeng Xue: Humbled and Honored to Receive the 2025 Eberhard F. Mammen Young Investigator Award
-
Mar 14, 2026, 19:13Abhilasha Singh: A Novel Mechanism of Cardiac Aging and Disruption of The Neurovascular Network
-
Mar 14, 2026, 19:08Saleh Owimer: The Critical Rules of Safe Blood Transfusion
-
Mar 14, 2026, 19:01Omar Adwan: Correcting Lipemic Samples in CBC Using the Plasma Replacement Method
-
Mar 14, 2026, 16:28Abdul Mannan: Advancing VWF Activity Testing Beyond VWF:RCo in Clinical Laboratories
-
Mar 14, 2026, 16:26Rida Fatima: When The Body’s Most Vital Production Unit Stops Working
-
Mar 14, 2026, 16:16Martin Haluzík: Metabolic Risk Factors and Therapeutic Opportunities in Cardiovascular Disease
-
Mar 14, 2026, 16:10Raffaella Colombatti: Proud to Have Authored the New Lancet Seminar on Sickle Cell Disease
-
Mar 14, 2026, 16:05Simon Senanu: D-Dimer – A Small Fragment with Big Clinical Significance